OR WAIT null SECS
February 02, 2024
Leading experts in the sector explore the value of third-party logistics providers when it comes to fortifying pharmaceutical supply chains.
February 01, 2024
In order to provide both profitability and medication access, a balancing act is required.
January 31, 2024
A look at the challenges that need to be addressed during the FDA stabilization period.
Under the DSCSA law, wholesale distributors, re-packagers, dispensers, and other third-party logistics providers must implement interoperable and electronic tracing of prescription products at the package level.
As a result, time to treatment for the brand Gilead product is expected to increase from 16 to 14 days.
January 30, 2024
The latest financial commitment adds 24,000 liters of biologics drug substance-capacity to the company’s network.
January 29, 2024
One lot of the company’s branded dextroamphetamine sulfate tablets is being removed from shelves nationwide due to a pharmacy receiving carbinoxamine maleate instead.
January 18, 2024
The predicted value is largely driven by manufacturers' prioritization of brand protection.
January 17, 2024
JAMA Health Forum details the DSCSA and stresses the value of protecting the pharmaceutical supply chain from adulterated products.
January 15, 2024
Roots Analysis report suggests increase can be attributed to the growing demand for advanced therapies and biologics.